Rocket


Overview
Financials
News + Filings

 
 

Dermavant Sciences Ltd Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsMar-31-19Mar-31-18
Revenues252.337.4
            Revenue growth574.5% 
Cost of goods sold0.00.0
Gross profit252.337.4
            Gross margin100.0%100.0%
Selling, general and administrative273.242.1
EBIT-255.8-42.8
            EBIT margin-101.4%-114.3%
Pre-tax income-255.2-42.4
Income taxes0.10.3
Net income-255.3-42.7
            Net margin-101.2%-114.2%
 
Diluted EPS($18.45)($3.45)
Shares outstanding (diluted)13.812.4
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy